What's new

Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised

May 23, 2025 - 17:35
 0
Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised
Human medicines European public assessment report (EPAR): Ebymect, dapagliflozin,metformin, Date of authorisation: 15/11/2015, Revision: 23, Status: Authorised
Read More

Tags:

Previous Article

Human medicines European public assessment report (EPAR): Janumet, sitagliptin,m...

Next Article

NGA hopes to award up to 10 Luno commercial analytics task orders this year

Related Posts

Questions and answers clinic on Product Management Service (PMS) Product User Interface (PUI) and Application Programming Interface (API) - September 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 18 September 2025, 10:00 (CEST) to 18 September 2025, 11:00 (CEST)

Questions and answers clinic on Product Management Serv...

May 15, 2025  0

Human medicines European public assessment report (EPAR): Korjuny, catumaxomab, Date of authorisation: 10/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR...

May 20, 2025  0

PSUSA/00010072/202409

PSUSA/00010072/202409

May 12, 2025  0